Tradestie Institutional Equity Comparison Engine

AGIO vs PTCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AGIO Overall Edge

AGIO Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Agios Pharmaceuticals, Inc. (AGIO) driven by superior Valuation, Momentum & Technical, Options & Structure while PTCT counters with relative strength in Growth & Margin. Fundamentally, AGIO trades at 2.5x Forward P/E with -297.7% operating margin (+330.0% YoY revenue) versus PTCT at 19.9x Forward P/E and 21.5% operating margin (+69.6% YoY). In options structure, AGIO sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro) against PTCT sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AGIO
AGIO 2.5x vs PTCT 19.9x Fwd P/E
Growth & Margin Winner PTCT
Op Margin -297.7% vs 21.5% ยท YoY +330.0% vs +69.6%
Momentum & Technical Winner AGIO
1Y -28.5% vs -17.8% ยท 52W Pos 34% vs 9%
Options & Structure Winner AGIO
UNCLASSIFIED (16th %ile IV) vs BREAKDOWN (17th %ile IV)
AGIO NASDAQ
Agios Pharmaceuticals, Inc.
Pharmaceutical Preparations
$30.42
-3.7% 1D
Market Cap $1.9B
1M Return -2.87%
1Y Return -28.49%
Forward P/E 2.5x
Unified AI Score
58.1 / 100 HOLD
Tech 81.0 Fund 62.0 Flow 50.0 Mom 53.3
PTCT NASDAQ
PTC Therapeutics, Inc.
Pharmaceutical Preparations
$61.62
-2.95% 1D
Market Cap $5.3B
1M Return +4.02%
1Y Return -17.79%
Forward P/E 19.9x
Unified AI Score
44.5 / 100 HOLD
Tech 46.0 Fund 52.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AGIO -28.49% PTCT -17.79% Spread: +10.7 pp (PTCT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AGIO TTM Op. Margin: -297.7% PTCT TTM Op. Margin: 21.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AGIO vs PTCT. Trailing 12-month operating profitability (AGIO -297.7% vs PTCT 21.5%) and valuation multiples (AGIO 2.5x vs PTCT 19.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AGIO (6) vs PTCT (4)
Institutional Metric AGIO PTCT Criterion Row Winner
Market Capitalization Scale $1.9B $5.3B Larger Scale PTCT
Trailing P/E Ratio Valuation 2.5x 19.4x Lower Multiple AGIO
Forward P/E Ratio Valuation 2.5x 19.9x Lower Multiple AGIO
Revenue Growth (YoY) Growth +330.0% +69.6% Higher Growth AGIO
Operating Margin (TTM) Profitability -297.7% 21.5% Higher Margin PTCT
Net Profit Margin Profitability -264.8% -9.2% Higher Margin PTCT
Return on Equity (ROE) Capital Efficiency -33.0% -7740.1% Higher ROE AGIO
52-Week Range Position Momentum 34% ($22โ€“$46) 9% ($59โ€“$91) Stronger Trend AGIO
Beta / 30D Volatility Risk Regime 1.12ฮฒ ยท 85% Vol 0.81ฮฒ ยท 58% Vol Lower Realized Risk PTCT
Unified Institutional Score Composite Signal 58.1 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite AGIO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AGIO vs PTCT Buy Guide
AGIO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live AGIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PTCT BREAKDOWN
91d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live PTCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AGIO nor PTCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.